Albemarle Corporation · ALB · FY2026 Q2 · Calendar Q3 2026

Albemarle Q2: Strong growth, tighter lithium markets, lower capex

The current analysis supports a constructive operating picture for Albemarle: strong Q2 growth, tight lithium inventories, raised specialties and stationary-storage outlooks, lower expected capex, and progress on DLE. The case remains conditional on supply availability, commodity pricing, project execution, and recovery from the CGP3 disruption.

Reported After market closeNYSEBasic Materials $13.32B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.75 Consensus $3.20
EPS surprise +17.2% Reported versus consensus
Reported revenue $1.74B Consensus $1.61B
Revenue surprise +8.5% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +5.5% Event window
SPY move -0.2% Same window
Abnormal move +5.7% Stock minus SPY
Volume 1.9× Versus trailing sessions
Subsequent drift +5.4% Up to 20 sessions
ALBSPY benchmark

Ask FN2 about ALB FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the current analysis shows stronger Q2 results, tighter reported lithium-market conditions, raised specialties and stationary-storage outlooks, lower expected capex, and a new operational disruption at Greenbushes CGP3 that was offset by performance elsewhere. DLE progress also advanced, with the pilot reporting over 90% recovery and 85% water recycling.

Guidance delta

Management raised its specialties and stationary-storage outlooks and lowered expected capital spending. The supplied analysis does not provide revised numerical guidance ranges.

Key takeaways

  • Q2 sales increased 31% year over year and adjusted EBITDA margins expanded to 49%, according to the supplied transcript analysis.
  • Management characterized lithium inventories as historically low, with demand outpacing supply.
  • A Greenbushes CGP3 fire disrupted operations, but other assets helped offset the impact; CGP3 was back online and is ramping toward full rate in early 2027.
  • The DLE pilot at Salar de Atacama achieved over 90% lithium recovery and 85% water recycling.
  • Cash generation was strong, with over 80% of earnings converted to operating cash and $638 million of free cash flow.

Management priorities

  • Advance the Salar de Atacama DLE project after permit approval.
  • Ramp CGP3 toward full run-rate in Q1 2027 and continue brownfield expansions at Wodgina and Talison.
  • Pursue additional brownfield projects, including Kings Mountain and Antofalla.
  • Maintain disciplined capital allocation while pursuing the high end of the $100 million to $150 million cost-productivity target.
  • Explore additional joint ventures and partnerships to broaden the resource base.

Follow ALB with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ALB EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $0.25 Q1 '24 actual $0.26, match Q2 '24 estimate $0.53 Q2 '24 actual $0.04, miss Q3 '24 estimate $-0.31 Q3 '24 actual $-1.55, miss Q2 '25 estimate $-0.83 Q2 '25 actual $0.11, beat Q3 '25 estimate $-0.86 Q3 '25 actual $-0.19, beat Q4 '25 estimate $-0.42 Q4 '25 actual $-0.53, miss Q1 '26 estimate $1.19 Q1 '26 actual $2.95, beat Q2 '26 estimate $3.20 Q2 '26 actual $3.75, beat Q3 '26 estimate $2.56 Q4 '26 estimate $3.17 Q1 '27 estimate $2.20
Show 1 more >

Analyst Consensus ?

ConsensusHold43 ratings
Bullish2046.5%
Neutral1944.2%
Bearish49.3%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$112.92Previous close
$68Low
$196.17Average
$320High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Neutral NeutralMaintainAug 25, 2026
Scotiabank Sector Outperform Sector OutperformMaintainAug 10, 2026
RBC Capital Outperform OutperformMaintainAug 10, 2026
Morgan Stanley Equal Weight Equal WeightMaintainAug 10, 2026
Evercore ISI Group In Line In LineMaintainAug 10, 2026
UBS Buy BuyMaintainAug 7, 2026
Truist Securities Buy BuyMaintainAug 7, 2026
Citigroup Buy BuyMaintainAug 7, 2026
BMO Capital Outperform OutperformMaintainAug 7, 2026
B of A Securities Buy BuyMaintainAug 7, 2026
Mizuho Neutral NeutralMaintainAug 5, 2026
Wells Fargo Equal Weight Equal WeightMaintainJun 4, 2026
Berenberg Hold HoldMaintainJun 2, 2026
Vertical Research Buy HoldUpgradeMay 26, 2026
Deutsche Bank Buy BuyMaintainMay 13, 2026
Argus Research Buy BuyMaintainMay 11, 2026
Baird Neutral OutperformDowngradeApr 17, 2026
Jefferies Buy BuyMaintainJan 28, 2026
Oppenheimer Outperform OutperformMaintainJan 21, 2026
Keybanc Sector Weight OverweightDowngradeJul 30, 2025
TD Securities Hold HoldMaintainMay 1, 2025
Piper Sandler Underweight UnderweightMaintainFeb 20, 2025
HSBC Hold BuyDowngradeJul 17, 2024
Loop Capital Buy BuyMaintainMar 15, 2024
TD Cowen Market Perform OutperformDowngradeJan 29, 2024
Credit Suisse Underperform UnderperformMaintainAug 3, 2023
Goldman Sachs Sell NeutralDowngradeDec 15, 2021
Cowen & Co. Outperform OutperformMaintainMar 10, 2021
SunTrust Robinson Humphrey Hold HoldMaintainMay 11, 2020
CFRA Hold BuyDowngradeApr 3, 2020
Seaport Global Neutral BuyDowngradeNov 14, 2019
Bank of America Underperform BuyDowngradeOct 28, 2019
Buckingham Research Neutral NeutralMaintainOct 3, 2019
Buckingham Neutral NeutralMaintainOct 3, 2019
Gabelli & Co. Buy BuyMaintainSep 12, 2019
Nomura Neutral NeutralMaintainAug 9, 2019
Argus Buy BuyMaintainFeb 23, 2018
Macquarie Outperform OutperformMaintainAug 19, 2015
BB&T Capital Buy BuyMaintainJul 8, 2015
Topeka Capital Buy HoldUpgradeJul 29, 2014
Topeka Buy HoldUpgradeJul 29, 2014
Sterne Agee Neutral BuyDowngradeOct 18, 2013
PiperJaffray Neutral OverweightDowngradeSep 24, 2013
Gilford Securities Hold BuyDowngradeJan 8, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $112.92. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
ScotiabankBen Isaacson$190$131.11 +68.3%Aug 10, 2026
Morgan StanleyVincent Andrews$161$131.11 +42.6%Aug 10, 2026
Truist FinancialPeter Osterland$225$128.49 +99.3%Aug 7, 2026
UBSAnalyst unavailable$175$128.86 +55.0%Aug 7, 2026
RBC CapitalAnalyst unavailable$166$118.83 +47.0%Jul 17, 2026
RBC CapitalAnalyst unavailable$257$177.4 +127.6%May 26, 2026
Vertical ResearchAnalyst unavailable$224$171.58 +98.4%May 26, 2026
ScotiabankBen Isaacson$215$191 +90.4%May 14, 2026
Deutsche BankDavid Begleiter$250$206.88 +121.4%May 12, 2026
RBC CapitalAnalyst unavailable$253$216.2 +124.1%May 11, 2026
Argus ResearchAnalyst unavailable$230$215 +103.7%May 11, 2026
UBSAnalyst unavailable$264$198.01 +133.8%May 8, 2026
Truist FinancialAnalyst unavailable$260$198.35 +130.3%May 8, 2026
RBC CapitalAnalyst unavailable$245$185.38 +117.0%Apr 24, 2026
Morgan StanleyAnalyst unavailable$189$186.22 +67.4%Apr 14, 2026
UBSAnalyst unavailable$230$172.35 +103.7%Apr 9, 2026
Truist FinancialPeter Osterland$210$158.91 +86.0%Mar 6, 2026
Berenberg BankAndres Castanos-Mollor$153$168.42 +35.5%Feb 23, 2026
Evercore ISIAnalyst unavailable$180$173.46 +59.4%Feb 18, 2026
RBC CapitalAnalyst unavailable$216$170.25 +91.3%Feb 17, 2026
Wells FargoAnalyst unavailable$165$166.35 +46.1%Feb 16, 2026
Morgan StanleyVincent Andrews$170$165.85 +50.5%Feb 13, 2026
Mizuho SecuritiesAnalyst unavailable$185$175.43 +63.8%Feb 12, 2026
Wells FargoAnalyst unavailable$174$189.51 +54.1%Jan 26, 2026
RBC CapitalArun Viswanathan$200$178.41 +77.1%Jan 21, 2026
OppenheimerAnalyst unavailable$207$176.56 +83.3%Jan 21, 2026
Truist FinancialPeter Osterland$205$172.54 +81.5%Jan 21, 2026
HSBCAnalyst unavailable$200$163.04 +77.1%Jan 19, 2026
Deutsche BankDavid Begleiter$185$169.33 +63.8%Jan 12, 2026
Mizuho SecuritiesAnalyst unavailable$156$167.82 +38.2%Jan 12, 2026
UBSJoshua Spector$205$167.58 +81.5%Jan 12, 2026
ScotiabankAnalyst unavailable$200$161.29 +77.1%Jan 12, 2026
Robert W. BairdAnalyst unavailable$210$158.15 +86.0%Jan 7, 2026
JefferiesLaurence Alexander$167$143.93 +47.9%Jan 5, 2026
RBC CapitalAnalyst unavailable$159$134.71 +40.8%Dec 18, 2025
Mizuho SecuritiesAnalyst unavailable$132$134.71 +16.9%Dec 18, 2025
Truist FinancialPeter Osterland$125$137.01 +10.7%Dec 17, 2025
Morgan StanleyVincent Andrews$147$133.72 +30.2%Dec 16, 2025
UBSAnalyst unavailable$185$119.14 +63.8%Dec 5, 2025
Deutsche BankDavid Begleiter$125$128.14 +10.7%Dec 3, 2025
Robert W. BairdAnalyst unavailable$113$128.33 +0.1%Dec 2, 2025
BMO CapitalJoel Jackson$136$121.39 +20.4%Nov 19, 2025
ScotiabankAnalyst unavailable$85$103.65 -24.7%Nov 10, 2025
Truist FinancialAnalyst unavailable$87$92.74 -23.0%Oct 20, 2025
Wells FargoAnalyst unavailable$90$96.24 -20.3%Oct 15, 2025
UBSAnalyst unavailable$85$92.69 -24.7%Oct 6, 2025
Mizuho SecuritiesAnalyst unavailable$92$87.61 -18.5%Oct 3, 2025
Robert W. BairdBen Kallo$68$87.08 -39.8%Aug 29, 2025
UBSJoshua Spector$89$82.71 -21.2%Aug 26, 2025
Deutsche BankAnalyst unavailable$74$68.56 -34.5%Aug 4, 2025
Robert W. BairdBen Kallo$60$71.58 -46.9%Jul 29, 2025
Mizuho SecuritiesJohn Roberts$76$71.82 -32.7%Jul 15, 2025
UBSJoshua Spector$57$74.27 -49.5%Jul 11, 2025
Piper SandlerCharles Neivert$68$61.08 -39.8%May 14, 2025
Mizuho SecuritiesAnalyst unavailable$85$75.51 -24.7%Mar 7, 2025
Morgan StanleyVincent Andrews$68$81.21 -39.8%Feb 18, 2025
Berenberg BankAndres Castanos-Mollor$102$81.65 -9.7%Nov 13, 2024
KeyBancAleksey Yefremov$127$98.56 +12.5%Nov 12, 2024
JefferiesLaurence Alexander$120$96.05 +6.3%Sep 27, 2024
BMO CapitalJoel Jackson$150$77.81 +32.8%Aug 16, 2024
Piper SandlerCharles Neivert$90$80.4 -20.3%Aug 8, 2024
RBC CapitalArun Viswanathan$111$81.05 -1.7%Aug 6, 2024
KeyBancAleksey Yefremov$132$83.8 +16.9%Aug 5, 2024
Berenberg BankAndres Castanos-Mollor$83$92.51 -26.5%Jul 31, 2024
Piper SandlerCharles Neivert$95$92.77 -15.9%Jun 25, 2024
UBSJoshua Spector$124$112.65 +9.8%Jun 13, 2024
Argus ResearchBill Selesky$166$112.65 +47.0%Jun 12, 2024
Piper SandlerCharles Neivert$122$124.38 +8.0%May 30, 2024
ScotiabankBen Isaacson$135$127.5 +19.6%May 21, 2024
Deutsche BankCorinne Blanchard$140$130.78 +24.0%May 7, 2024
ScotiabankBen Isaacson$150$129.65 +32.8%May 6, 2024
RBC CapitalArun Viswanathan$157$128.1 +39.0%May 6, 2024
Berenberg BankAndres Castanos-Mollor$160$127.65 +41.7%Apr 11, 2024
Loop Capital MarketsChris Kapsch$162$131.17 +43.5%Mar 28, 2024
Loop Capital MarketsJoel Jackson$180$122.66 +59.4%Nov 7, 2023
Piper SandlerCharles Neivert$155$135.32 +37.3%Oct 25, 2023
Robert W. BairdBen Kallo$288$203.98 +155.0%May 15, 2023
KeyBancAleksey Yefremov$270$194.51 +139.1%May 11, 2023
UBSAnalyst unavailable$250$235.62 +121.4%Jan 11, 2023
CitigroupAnalyst unavailable$295$247.86 +161.2%Dec 15, 2022
Morgan StanleyAnalyst unavailable$155$264.64 +37.3%Nov 28, 2022
JefferiesJonathan Petersen$320$212.04 +183.4%Jun 20, 2022
Morgan StanleyAnalyst unavailable$135$242.41 +19.6%May 9, 2022
CitigroupPJ Juvekar$244$190.37 +116.1%Feb 18, 2022
UBSJohn Roberts$320$190.76 +183.4%Feb 18, 2022
Wells FargoEdward Kelly$215$190.37 +90.4%Feb 18, 2022
OppenheimerColin Rusch$307$196.61 +171.9%Feb 17, 2022
Mizuho SecuritiesChris Parkinson$243$196.61 +115.2%Feb 17, 2022
HSBCSanthosh Seshadri$280$205.2 +148.0%Jan 26, 2022
Cowen & Co.David Deckelbaum$275$232.62 +143.5%Dec 26, 2021
Goldman SachsRobert Koort$205$238.9 +81.5%Dec 15, 2021
Loop Capital MarketsChris Kapsch$280$214.42 +148.0%Oct 4, 2021
JefferiesLaurence Alexander$300$218.16 +165.7%Sep 30, 2021
Argus ResearchBill Selesky$278$237.75 +146.2%Aug 10, 2021
Morgan StanleyVincent Andrews$80$158.27 -29.2%May 10, 2021
Show less

Track every rating change on ALB the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry.…

Historical context

All ALB earnings

Basic Materials peers this season

Latest reports in the same sector
CompanyQuarterEPS surpriseMarket moveHeadline
HMY Harmony Gold Mining Company Limited FY2026 Q4 · Calendar Q3 2026 0.0% -6.2% Harmony Gold posts record FY2026 while Eva Copper risks remain

Latest beats and misses

Who reports next

Get the ALB recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-06T20:11:43.924599+00:00
  2. FN2 earnings calendar · 2026-09-10T01:23:10.351880+00:00
  3. Polygon adjusted daily market bars · 2026-09-22T11:36:07.835061+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T11:36:07.832213+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-22. For educational purposes only; not investment advice.